HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells

Chi N. Chan, Benjamin Trinité, Caroline S. Lee, Saurabh Mahajan, Akanksha Anand, Dominik Wodarz, Steffanie Sabbaj, Anju Bansal, Paul A. Goepfert, David Levy

Research output: Contribution to journalArticle

Abstract

Background: HIV-1 integration is prone to a high rate of failure, resulting in the accumulation of unintegrated viral genomes (uDNA) in vivo and in vitro. uDNA can be transcriptionally active, and circularized uDNA genomes are biochemically stable in non-proliferating cells. Resting, non-proliferating CD4 T cells are prime targets of HIV-1 infection and latently infected resting CD4 T cells are the major barrier to HIV cure. Our prior studies demonstrated that uDNA generates infectious virions when T cell activation follows rather than precedes infection. Results: Here, we characterize in primary resting CD4 T cells the dynamics of integrated and unintegrated virus expression, genome persistence and sensitivity to latency reversing agents. Unintegrated HIV-1 was abundant in directly infected resting CD4 T cells. Maximal gene expression from uDNA was delayed compared with integrated HIV-1 and was less toxic, resulting in uDNA enrichment over time relative to integrated proviruses. Inhibiting integration with raltegravir shunted the generation of durable latency from integrated to unintegrated genomes. Latent uDNA was activated to de novo virus production by latency reversing agents that also activated latent integrated proviruses, including PKC activators, histone deacetylase inhibitors and P-TEFb agonists. However, uDNA responses displayed a wider dynamic range, indicating differential regulation of expression relative to integrated proviruses. Similar to what has recently been demonstrated for latent integrated proviruses, one or two applications of latency reversing agents failed to activate all latent unintegrated genomes. Unlike integrated proviruses, uDNA gene expression did not down modulate expression of HLA Class I on resting CD4 T cells. uDNA did, however, efficiently prime infected cells for killing by HIV-1-specific cytotoxic T cells. Conclusions: These studies demonstrate that contributions by unintegrated genomes to HIV-1 gene expression, virus production, latency and immune responses are inherent properties of the direct infection of resting CD4 T cells. Experimental models of HIV-1 latency employing directly infected resting CD4 T cells should calibrate the contribution of unintegrated HIV-1.

Original languageEnglish (US)
Article number1
JournalRetrovirology
Volume13
Issue number1
DOIs
StatePublished - Jan 5 2016

Fingerprint

Virus Latency
HIV-1
Genome
Proviruses
T-Lymphocytes
Infection
Gene Expression
Positive Transcriptional Elongation Factor B
Histone Deacetylase Inhibitors
Viral Genome
Poisons
Virion
HIV Infections
Theoretical Models
HIV
Viruses

Keywords

  • Cytotoxic T cells
  • HIV-1
  • Integration
  • Latency
  • Raltegravir
  • Unintegrated DNA

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells. / Chan, Chi N.; Trinité, Benjamin; Lee, Caroline S.; Mahajan, Saurabh; Anand, Akanksha; Wodarz, Dominik; Sabbaj, Steffanie; Bansal, Anju; Goepfert, Paul A.; Levy, David.

In: Retrovirology, Vol. 13, No. 1, 1, 05.01.2016.

Research output: Contribution to journalArticle

Chan, CN, Trinité, B, Lee, CS, Mahajan, S, Anand, A, Wodarz, D, Sabbaj, S, Bansal, A, Goepfert, PA & Levy, D 2016, 'HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells', Retrovirology, vol. 13, no. 1, 1. https://doi.org/10.1186/s12977-015-0234-9
Chan, Chi N. ; Trinité, Benjamin ; Lee, Caroline S. ; Mahajan, Saurabh ; Anand, Akanksha ; Wodarz, Dominik ; Sabbaj, Steffanie ; Bansal, Anju ; Goepfert, Paul A. ; Levy, David. / HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells. In: Retrovirology. 2016 ; Vol. 13, No. 1.
@article{d83c8ded1ba54ec1bd2376f209dbf3f1,
title = "HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells",
abstract = "Background: HIV-1 integration is prone to a high rate of failure, resulting in the accumulation of unintegrated viral genomes (uDNA) in vivo and in vitro. uDNA can be transcriptionally active, and circularized uDNA genomes are biochemically stable in non-proliferating cells. Resting, non-proliferating CD4 T cells are prime targets of HIV-1 infection and latently infected resting CD4 T cells are the major barrier to HIV cure. Our prior studies demonstrated that uDNA generates infectious virions when T cell activation follows rather than precedes infection. Results: Here, we characterize in primary resting CD4 T cells the dynamics of integrated and unintegrated virus expression, genome persistence and sensitivity to latency reversing agents. Unintegrated HIV-1 was abundant in directly infected resting CD4 T cells. Maximal gene expression from uDNA was delayed compared with integrated HIV-1 and was less toxic, resulting in uDNA enrichment over time relative to integrated proviruses. Inhibiting integration with raltegravir shunted the generation of durable latency from integrated to unintegrated genomes. Latent uDNA was activated to de novo virus production by latency reversing agents that also activated latent integrated proviruses, including PKC activators, histone deacetylase inhibitors and P-TEFb agonists. However, uDNA responses displayed a wider dynamic range, indicating differential regulation of expression relative to integrated proviruses. Similar to what has recently been demonstrated for latent integrated proviruses, one or two applications of latency reversing agents failed to activate all latent unintegrated genomes. Unlike integrated proviruses, uDNA gene expression did not down modulate expression of HLA Class I on resting CD4 T cells. uDNA did, however, efficiently prime infected cells for killing by HIV-1-specific cytotoxic T cells. Conclusions: These studies demonstrate that contributions by unintegrated genomes to HIV-1 gene expression, virus production, latency and immune responses are inherent properties of the direct infection of resting CD4 T cells. Experimental models of HIV-1 latency employing directly infected resting CD4 T cells should calibrate the contribution of unintegrated HIV-1.",
keywords = "Cytotoxic T cells, HIV-1, Integration, Latency, Raltegravir, Unintegrated DNA",
author = "Chan, {Chi N.} and Benjamin Trinit{\'e} and Lee, {Caroline S.} and Saurabh Mahajan and Akanksha Anand and Dominik Wodarz and Steffanie Sabbaj and Anju Bansal and Goepfert, {Paul A.} and David Levy",
year = "2016",
month = "1",
day = "5",
doi = "10.1186/s12977-015-0234-9",
language = "English (US)",
volume = "13",
journal = "Retrovirology",
issn = "1742-4690",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells

AU - Chan, Chi N.

AU - Trinité, Benjamin

AU - Lee, Caroline S.

AU - Mahajan, Saurabh

AU - Anand, Akanksha

AU - Wodarz, Dominik

AU - Sabbaj, Steffanie

AU - Bansal, Anju

AU - Goepfert, Paul A.

AU - Levy, David

PY - 2016/1/5

Y1 - 2016/1/5

N2 - Background: HIV-1 integration is prone to a high rate of failure, resulting in the accumulation of unintegrated viral genomes (uDNA) in vivo and in vitro. uDNA can be transcriptionally active, and circularized uDNA genomes are biochemically stable in non-proliferating cells. Resting, non-proliferating CD4 T cells are prime targets of HIV-1 infection and latently infected resting CD4 T cells are the major barrier to HIV cure. Our prior studies demonstrated that uDNA generates infectious virions when T cell activation follows rather than precedes infection. Results: Here, we characterize in primary resting CD4 T cells the dynamics of integrated and unintegrated virus expression, genome persistence and sensitivity to latency reversing agents. Unintegrated HIV-1 was abundant in directly infected resting CD4 T cells. Maximal gene expression from uDNA was delayed compared with integrated HIV-1 and was less toxic, resulting in uDNA enrichment over time relative to integrated proviruses. Inhibiting integration with raltegravir shunted the generation of durable latency from integrated to unintegrated genomes. Latent uDNA was activated to de novo virus production by latency reversing agents that also activated latent integrated proviruses, including PKC activators, histone deacetylase inhibitors and P-TEFb agonists. However, uDNA responses displayed a wider dynamic range, indicating differential regulation of expression relative to integrated proviruses. Similar to what has recently been demonstrated for latent integrated proviruses, one or two applications of latency reversing agents failed to activate all latent unintegrated genomes. Unlike integrated proviruses, uDNA gene expression did not down modulate expression of HLA Class I on resting CD4 T cells. uDNA did, however, efficiently prime infected cells for killing by HIV-1-specific cytotoxic T cells. Conclusions: These studies demonstrate that contributions by unintegrated genomes to HIV-1 gene expression, virus production, latency and immune responses are inherent properties of the direct infection of resting CD4 T cells. Experimental models of HIV-1 latency employing directly infected resting CD4 T cells should calibrate the contribution of unintegrated HIV-1.

AB - Background: HIV-1 integration is prone to a high rate of failure, resulting in the accumulation of unintegrated viral genomes (uDNA) in vivo and in vitro. uDNA can be transcriptionally active, and circularized uDNA genomes are biochemically stable in non-proliferating cells. Resting, non-proliferating CD4 T cells are prime targets of HIV-1 infection and latently infected resting CD4 T cells are the major barrier to HIV cure. Our prior studies demonstrated that uDNA generates infectious virions when T cell activation follows rather than precedes infection. Results: Here, we characterize in primary resting CD4 T cells the dynamics of integrated and unintegrated virus expression, genome persistence and sensitivity to latency reversing agents. Unintegrated HIV-1 was abundant in directly infected resting CD4 T cells. Maximal gene expression from uDNA was delayed compared with integrated HIV-1 and was less toxic, resulting in uDNA enrichment over time relative to integrated proviruses. Inhibiting integration with raltegravir shunted the generation of durable latency from integrated to unintegrated genomes. Latent uDNA was activated to de novo virus production by latency reversing agents that also activated latent integrated proviruses, including PKC activators, histone deacetylase inhibitors and P-TEFb agonists. However, uDNA responses displayed a wider dynamic range, indicating differential regulation of expression relative to integrated proviruses. Similar to what has recently been demonstrated for latent integrated proviruses, one or two applications of latency reversing agents failed to activate all latent unintegrated genomes. Unlike integrated proviruses, uDNA gene expression did not down modulate expression of HLA Class I on resting CD4 T cells. uDNA did, however, efficiently prime infected cells for killing by HIV-1-specific cytotoxic T cells. Conclusions: These studies demonstrate that contributions by unintegrated genomes to HIV-1 gene expression, virus production, latency and immune responses are inherent properties of the direct infection of resting CD4 T cells. Experimental models of HIV-1 latency employing directly infected resting CD4 T cells should calibrate the contribution of unintegrated HIV-1.

KW - Cytotoxic T cells

KW - HIV-1

KW - Integration

KW - Latency

KW - Raltegravir

KW - Unintegrated DNA

UR - http://www.scopus.com/inward/record.url?scp=84959121725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959121725&partnerID=8YFLogxK

U2 - 10.1186/s12977-015-0234-9

DO - 10.1186/s12977-015-0234-9

M3 - Article

C2 - 26728316

AN - SCOPUS:84959121725

VL - 13

JO - Retrovirology

JF - Retrovirology

SN - 1742-4690

IS - 1

M1 - 1

ER -